Geneva Advisors’s NeoGenomics NEO Stock Holding History

Geneva Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$1.11M	Buy	+123,771	New	+$982K	0.02%	346
2014 Q4	–	Sell	-10,000	Closed	-$52K	–	732
2014 Q3	$52K	Hold	10,000	–	–	﹤0.01%	644
2014 Q2	$33K	Hold	10,000	–	–	﹤0.01%	672
2014 Q1	$35K	Hold	10,000	–	–	﹤0.01%	646
2013 Q4	$36K	Hold	10,000	–	–	﹤0.01%	531
2013 Q3	$30K	Hold	10,000	–	–	﹤0.01%	493
2013 Q2	$40K	Buy	+10,000	New	+$38.1K	﹤0.01%	421

Other funds holding NEO

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Geneva Advisors's NEO Position: Q2 2017 in Review

Geneva Advisors opened a new position in NeoGenomics (NEO) in Q2 2017: 123,771 shares worth $1.11M. The stake represents 0.02% of the portfolio and ranks #346 among its holdings. This is a return to the name: Geneva Advisors previously reported a position in NEO as recently as Q3 2014.

Geneva Advisors first reported a position in NEO in Q2 2013 and has held it in 7 quarters since. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

Geneva Advisors held 123,771 shares of NeoGenomics worth $1.11M as of Q2 2017.
NeoGenomics was a new Geneva Advisors position in Q2 2017.
NeoGenomics made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #346 holding.
Geneva Advisors first reported a position in NeoGenomics in Q2 2013 and has held it in 7 quarters since.
134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.